Literature DB >> 28110484

Upregulation of 20-HETE Synthetic Cytochrome P450 Isoforms by Oxygen-Glucose Deprivation in Cortical Neurons.

Hui Zhang1,2, John R Falck3, Richard J Roman4, David R Harder5,6, Raymond C Koehler2, Zeng-Jin Yang7.   

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor, is a cytochrome P450 (CYP) 4A/4F-derived metabolite of arachidonic acid. Inhibition of 20-HETE synthesis protects brain from ischemic injury. However, that protection is not associated with changes in cerebral blood flow. The present study examined whether CYP4A isoforms are expressed in neurons, whether they produce 20-HETE in neurons, and whether neuronally derived 20-HETE exerts direct neurotoxicity after oxygen-glucose deprivation (OGD). The expression of Cyp4a10 and Cyp4a12a mRNA in cultured mouse cortical neurons increased significantly at 1 and 3 h after exposure to 1 h of OGD. Reoxygenation also markedly augmented the expression of CYP4A protein in neurons and increased 20-HETE levels in the culture medium. Cell viability after OGD increased after treatment with a 20-HETE synthesis inhibitor or an antagonist. That effect was reversed by co-administration of a 20-HETE agonist. These results indicate that neurons express Cyp4a10 and 4a12a, that expression of these isoforms is upregulated by OGD stress, and that neuronally derived 20-HETE directly contributes to neuronal death after reoxygenation.

Entities:  

Keywords:  20-HETE; Cytochrome P450; Eicosanoid; Ischemia; Oxygen–glucose deprivation

Mesh:

Substances:

Year:  2017        PMID: 28110484      PMCID: PMC5522363          DOI: 10.1007/s10571-017-0462-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  28 in total

1.  BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia.

Authors:  N Plesnila; S Zinkel; D A Le; S Amin-Hanjani; Y Wu; J Qiu; A Chiarugi; S S Thomas; D S Kohane; S J Korsmeyer; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 2.  Vascular actions of 20-HETE.

Authors:  Samantha L Hoopes; Victor Garcia; Matthew L Edin; Michal L Schwartzman; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-03-23       Impact factor: 3.072

3.  Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.

Authors:  Samuel M Poloyac; Yuqing Zhang; Robert R Bies; Patrick M Kochanek; Steven H Graham
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-29       Impact factor: 6.200

4.  Expression of CYP 4A ω-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes.

Authors:  Debebe Gebremedhin; David X Zhang; Koryn A Carver; Nicole Rau; Kevin R Rarick; Richard J Roman; David R Harder
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-05-09       Impact factor: 3.072

Review 5.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

Review 6.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 7.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

Review 8.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 9.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

Authors:  David R Nelson; Darryl C Zeldin; Susan M G Hoffman; Lois J Maltais; Hester M Wain; Daniel W Nebert
Journal:  Pharmacogenetics       Date:  2004-01

10.  Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.

Authors:  Yu Tanaka; Tomohiro Omura; Misako Fukasawa; Nobuko Horiuchi; Noriyuki Miyata; Toshiya Minagawa; Shigeru Yoshida; Shiro Nakaike
Journal:  Neurosci Res       Date:  2007-09-06       Impact factor: 3.304

View more
  8 in total

1.  Administration of a 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor Improves Outcome in a Rat Model of Pediatric Traumatic Brain Injury.

Authors:  Shiyu Shu; Zhi Zhang; Dawn Spicer; Ewa Kulikowicz; Ke Hu; Savalan Babapoor-Farrokhran; Sujatha Kannan; Raymond C Koehler; Courtney L Robertson
Journal:  Dev Neurosci       Date:  2019-09-25       Impact factor: 2.984

Review 2.  Perinatal hypoxic-ischemic brain injury in large animal models: Relevance to human neonatal encephalopathy.

Authors:  Raymond C Koehler; Zeng-Jin Yang; Jennifer K Lee; Lee J Martin
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-28       Impact factor: 6.200

3.  20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.

Authors:  Xiaoning Han; Xiaochun Zhao; Xi Lan; Qian Li; Yufeng Gao; Xi Liu; Jieru Wan; Zengjin Yang; Xuemei Chen; Weidong Zang; Austin M Guo; John R Falck; Raymond C Koehler; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-27       Impact factor: 6.200

4.  Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review.

Authors:  Shashank Shekhar; Ruen Liu; Olivia K Travis; Richard J Roman; Fan Fan
Journal:  J Pharm Sci Exp Pharmacol       Date:  2017-10-27

Review 5.  The contribution of TRPV1 channel to 20-HETE-Aggravated ischemic neuronal injury.

Authors:  Xiaofan Zhang; Nagat El Demerdash; John R Falck; Sailu Munnuri; Raymond C Koehler; Zeng-Jin Yang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-07-06       Impact factor: 3.072

6.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

Review 7.  Cytochrome P450 eicosanoids in cerebrovascular function and disease.

Authors:  Catherine M Davis; Xuehong Liu; Nabil J Alkayed
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

8.  Benign Regulation of the Astrocytic Phospholipase A2-Arachidonic Acid Pathway: The Underlying Mechanism of the Beneficial Effects of Manual Acupuncture on CBF.

Authors:  Ning Ding; Jing Jiang; Huiling Tian; Shun Wang; Zhigang Li
Journal:  Front Neurosci       Date:  2020-02-04       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.